BMC Gastroenterology

Table 3 Risk of gallstones in multivariate analyses of two different age groups

From: Strong association between metabolically-abnormal obesity and gallstone disease in adults under 50 years

Variables	Age < 50					Age ≥ 50
Variables	cOR	95% CI	adj. OR	95% CI	p	cOR	95% CI	adj. OR	95% CI	p
Sex	0.90	0.51–1.59	0.92	0.32–2.60	0.87	1.05	0.75–1.47	0.79	0.49–1.27	0.32
Bil-T	0.74	0.36–1.51	1.08	0.49–2.38	0.85	1.46	1.01–2.11	1.44	0.95–2.16	0.08
GOT	0.97	0.94–1.01	0.94	0.87–1.02	0.13	1.02	1.01–1.03	1.01	0.99–1.03	0.38
GPT	1.00	0.98–1.01	1.02	0.98–1.05	0.31	1.01	1.00–1.02	1.00	0.99–1.02	0.88
rGT	1.00	0.98–1.01	1.00	0.98–1.02	0.89	1.00	1.00–1.01	1.00	1.00–1.01	0.28
ALP	0.99	0.97–1.01	0.99	0.97–1.01	0.45	1.01	1.00–1.01	1.00	1.00–1.01	0.34
TC	0.99	0.98–1.00	0.98	0.96–1.01	0.15	1.00	0.99–1.00	0.99	0.98–1.01	0.30
LDL	1.00	0.99–1.01	1.01	0.99–1.04	0.38	1.00	0.99–1.00	1.01	0.99–1.02	0.43
Uric acid	1.01	0.84–1.21	0.94	0.71–1.25	0.65	1.18	1.06–1.31	1.13	0.98–1.30	0.09
BUN	1.02	0.95–1.10	1.06	0.95–1.18	0.32	1.02	0.98–1.05	1.00	0.95–1.05	0.98
Cr	0.57	0.11–2.86	0.50	0.04–6.37	0.59	1.34	0.81–2.20	1.23	0.55–2.78	0.61
HBV	1.22	0.54–2.76	1.14	0.46–2.80	0.77	0.91	0.51–1.61	0.99	0.54–1.80	0.97
HCV	–	–	0.00	< 0.001	1.00	2.86	1.68–4.88	2.58	1.43–4.68	< 0.05
Four phenotypes^a	1.50	1.21–1.86	1.73	1.32–2.28	< 0.001	1.18	1.04–1.34	1.10	0.94–1.27	0.23

ALP alkaline phosphatase, ALT alanine transaminase, AST aspartate transaminase, Bil-T total bilirubin, ALP alkaline phosphatase, AST aspartate transaminase, Bil-T total bilirubin, LDL low-density lipoprotein, TC total cholesterol, HBV hepatitis B virus, HCV hepatitis C virus; ^aFour phenotypes: MHNO, MHO, MANO and MAO

Back to article page

ISSN: 1471-230X

Contact us

Submission enquiries: bmcgastroenterology@biomedcentral.com
General enquiries: ORSupport@springernature.com